Bohdan V. Bobovskyi
Research Subjects
Research Interests
Bohdan V. Bobovskyi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Bohdan S. Sosunovych
Enamine (Ukraine)
1 shared publication - Bohdan V. Vashchenko
Enamine Ltd., Kyiv, Ukraine
1 shared publication - Dmytro Lesyk
Taras Shevchenko National University of Kyiv
1 shared publication - Igor I. Gerus
V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine, Kyiv, Ukraine
1 shared publication - Kostiantyn Melnykov
Taras Shevchenko National University of Kyiv
1 shared publication - Oleksandr O. Grygorenko
Enamine Ltd., Winston Churchill Street 78, Kyїv, Ukraine, 02094
1 shared publication
Latest Publications
- Open Access
- 17 December 2025
- Published by American Chemical Society (ACS) in ChemRxiv
α-Fluoroalkyl-Substituted Cyclopentane Building Blocks for Drug Discovery
A scalable synthesis of α-fluoroalkyl-substituted cyclopentane building blocks was developed. An entry into these chemotypes relied on α-fluoromethylation of cyclopentane carboxylate (for CH₂F-substituted substrates) and the deoxofluorination of the corresponding aldehyde or carboxylic acid (for CHF₂- and CF₃-substituted substrates) to access fluorine-containing esters, which were further diversified into various building blocks containing functional groups relevant to medicinal chemistry applications. The impact of fluoroalkyl substituent (CH₂F/CHF₂/CF₃) on the physicochemical properties of the synthesized derivatives was evaluated by experimental determination of their pKₐ and LogP values.
- 17 December 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open Accessα-Fluoroalkyl-Substituted Cyclopentane Building Blocks for Drug Discovery
A scalable synthesis of α-fluoroalkyl-substituted cyclopentane building blocks was developed. An entry into these chemotypes relied on α-fluoromethylation of cyclopentane carboxylate (for CH₂F-substituted substrates) and the deoxofluorination of the corresponding aldehyde or carboxylic acid (for CHF₂- and CF₃-substituted substrates) to access fluorine-containing esters, which were further diversified into various building blocks containing functional groups relevant to medicinal chemistry applications. The impact of fluoroalkyl substituent (CH₂F/CHF₂/CF₃) on the physicochemical properties of the synthesized derivatives was evaluated by experimental determination of their pKₐ and LogP values.